DNA Electronics to present at UKTI’s Healthcare and Life Sciences Summit
23 July 2012
DNA Electronics Ltd, a developer of semiconductor solutions for real-time DNA and RNA detection, has announced that Chairman and CEO Professor Chris Toumazou FRS will be presenting at the Healthcare and Life Sciences Global Business Summit on 2 August.
The Summit is hosted by UK Trade & Investment (UKTI) as part of the business events around the London Olympic games.
Professor Toumazou will join other key innovators, dignitaries
and industry figures from the UK life sciences community who have
been invited to address delegates on the future of the sector.
The event is being hosted by Lord Green of Hurstpierpoint, Minister of State for Trade and Investment and Professor Lord Darzi of Denham, UK Business Ambassador for the Life Sciences and Chair of the Institute of Global Health Innovation at Imperial College London.
The one-day gathering will bring together an impressive cadre of speakers joined by top industrialists and entrepreneurs, eminent clinicians and researchers, leaders from the UK’s NHS and Health Ministers from around the world. Key themes explored during the summit will include translational research to develop novel therapeutics and medical technologies, and the expanding role of informatics and digital technology in healthcare delivery. The seminar programme will also consider how the UK is contributing to life sciences research and healthcare development at an international level.
Professor Toumazou’s presentation, “Disposable semiconductor healthcare — from the bedside to point of care genetics” will explore how a revolution in genetics and molecular biology is being driven by the confluence of advances in life science and semiconductor-based technologies. A key disruptive innovation that will be highlighted is the first label-free DNA amplification and detection based upon ion-sensitive, field-effect transistor technology, which is enabling the creation of on-the-spot DNA diagnostic tests.
Professor Toumazou will examine the technology trends and
business models for rapid, lab-free and pipette-free DNA diagnostic
testing, and the transformative opportunities it presents in global
Prof. Toumazou’s innovation has culminated in the world’s first DNA logic on standard CMOS technology. DNA Electronics has worldwide non-exclusive licensing agreements with Roche’s 454 Life Sciences and Ion Torrent (Life Technologies Inc.) for the field of semiconductor sequencing, enabling these global leaders to access certain parts of the DNA Electronics proprietary technology portfolio.
In March 2012, DNA Electronics announced that it is licensing its ground-breaking Genalysis technology platform for rapid, lab-free DNA detection to geneOnyx, a company that is delivering on-the-spot genetic analytics services for cosmetics and skincare applications.
Global Business Summit on Healthcare and Life Sciences, 2 August